Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Conclusions About Benefits and Harms (2)
Study withdrawals were rare, suggesting that rhGH treatment was well tolerated. Fasting blood glucose was elevated by rhGH. The evidence is insufficient to evaluate whether rhGH treatment exacerbates existing risks for diabetes or cancer.
Keywords: CF | HGH | cystic fibrosis | health | human growth hormone | pulmonary function | recombinant human growth hormone | rhGH
- Phung OJ, Coleman CI, Baker EL, et al. Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis. AHRQ Comparative Effectiveness Review No. 23 (Prepared by University of Connecticut-Hartford Hospital Evidence-based Practice Center under Contract No. 290-2007-10067-I). Rockville, MD: Agency for Healthcare Research and Quality; October 2010. AHRQ Publication No. 11-EHC003-EF.
Your slide tray is being processed.